Differences Between Allergy Testing Methods
Skin prick testing (SPT) is generally the preferred first-line method for detecting IgE-mediated allergies, while serum-specific IgE (sIgE) testing serves as a complementary alternative when SPT cannot be performed or to confirm sensitization, though both tests detect sensitization rather than clinical allergy and neither alone is diagnostic. 1, 2
Key Methodological Differences
What Each Test Measures
Skin Prick Testing (SPT): Detects IgE antibodies bound to cutaneous mast cells in the skin. Results appear within 15-20 minutes as a wheal-and-flare response 1
Serum-Specific IgE Testing: Measures circulating IgE antibodies in the blood using fluorescence-labeled antibody assays (the term "RAST" is outdated and should be abandoned) 1
14-Regional Specific IgE Panel: This refers to testing multiple allergens simultaneously via blood draw, typically covering common environmental and food allergens in a geographic region
Critical distinction: Because SPT measures mast cell-bound IgE and serum testing measures circulating IgE, their results may not always correlate 1. Studies show substantial discordance between the two methods—using only one testing method may misdiagnose approximately 25% of allergically sensitized patients as non-sensitized 3.
Performance Characteristics
Sensitivity and Specificity Trade-offs
Skin Prick Testing:
- High sensitivity for certain allergens (90-94% for fresh cow's milk and raw egg) 4
- Better at ruling out allergies when negative
- Detects more additional sensitizations than serum testing when used sequentially 5
Serum-Specific IgE Testing:
- Higher specificity, particularly for component testing (92-95% for specific components like Ara h 2 for peanut, Cor a 14 for hazelnut) 4
- Better at confirming true allergy when positive
- Overall concordance with SPT ranges from 63-93% depending on the allergen 6, 7
The most recent high-quality meta-analysis from 2024 demonstrates that SPT with fresh extracts has superior sensitivity, while component-specific IgE testing has superior specificity for confirming clinical allergy 4.
When to Use Each Method
Skin Prick Testing is Preferred When:
- Patient can discontinue antihistamines for 3-7 days
- No extensive dermatitis, eczema, or dermatographism present
- Immediate results needed for clinical decision-making
- Cost is a consideration (SPT is more cost-effective per beneficiary: $247 vs $161 for sIgE) 8
Serum-Specific IgE Testing is Indicated When:
- Antihistamines cannot be discontinued 1
- Extensive skin disease prevents reliable SPT 1
- Patient has severe dermatographism
- Risk of severe systemic reaction makes SPT unsafe
- Remote testing is needed (no specialist visit required)
- Confirming sensitization with high specificity using component testing 4
The 14-Regional IgE Panel Specifically:
Avoid broad multi-allergen panels without clinical suspicion—these lead to overdiagnosis, unnecessary food avoidance, psychological harm, and financial waste 9. Current guidelines explicitly recommend against using sIgE food panel testing without targeted clinical suspicion 9.
Critical Pitfalls to Avoid
Neither test is diagnostic alone: Both SPT and sIgE detect sensitization, not clinical allergy. The presence of specific IgE antibodies does not necessarily indicate clinical sensitivity 1, 2. Oral food challenge remains the gold standard for diagnosis.
Results are not interchangeable between laboratories: Different assay systems (ImmunoCAP, Turbo-MP, Immulite) provide significantly different measurements for the same serum samples. Predictive values established for one system cannot be applied to another 1.
Undetectable levels don't rule out allergy: Undetectable sIgE levels occasionally occur in patients with true IgE-mediated food allergy. When history is highly suggestive, proceed to supervised oral food challenge 1.
Testing without clinical correlation is harmful: Positive tests without corresponding symptoms and exposure history should not guide treatment. This is especially problematic with broad panels 2, 9.
Practical Algorithm
Step 1: Obtain detailed history of suspected allergen exposure and symptoms
Step 2: If SPT is feasible (no contraindications) → Perform SPT first as it has higher sensitivity and lower cost
Step 3: If SPT is contraindicated or negative but clinical suspicion remains high → Perform targeted sIgE testing (not broad panels)
Step 4: For confirming clinical allergy when either test is positive → Consider component-specific IgE testing for higher specificity 4
Step 5: When both tests are negative but clinical suspicion persists → Proceed to supervised oral food challenge 1
The complementary nature of these tests means they should not be viewed as competing alternatives but rather as tools that provide different information—SPT for sensitive screening and sIgE (especially component testing) for specific confirmation 3, 4.